Neither Angel nor Demon:
Generative AI’s Role in Pharmaceutical Companies
Join the discussion to explore the promise…and potential pitfalls.
*The webinar took place March 16. If you would like to watch the recording, please fill out the form to the right.
Join Orbita to learn more about models like OpenAI/ChatGPT – and specifically how pharmaceutical companies can leverage them to communicate with patients and HCPs more effectively and introduce greater efficiency into routine workflows.
During this webinar, you will discover:
- Strategies for leveraging generative AI to improve operational efficiency and reduce development costs
- Tools to help ensure the information developed using generative AI is accurate, consistent and ready for regulatory review
- Guardrails needed to ensure these models meet specific privacy, regulatory and organizational needs